SUSTAINED RELEASE PHARMACEUTICAL DOSAGE UNITS

SUSTAINED RELEASE PHARMACEUTICAL DOSAGE UNITS

A sustained release pharmaceutical formulation is disclosed having the capability of a linear rate of drug release over a significant period (e.g. at least 20 hours). The formulation essentially comprises a shaped, solid formulation containing a drug and a non-cross-linked hydrophilic polymer which...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: MICHAEL GORDON BROOK
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MICHAEL GORDON BROOK
description A sustained release pharmaceutical formulation is disclosed having the capability of a linear rate of drug release over a significant period (e.g. at least 20 hours). The formulation essentially comprises a shaped, solid formulation containing a drug and a non-cross-linked hydrophilic polymer which constitutes the binder for the formulation, said polymer having a swell factor between about 50 and 250 % such that when the formulation is contacted with body fluid it swells and becomes soft and rubbery but retains its integrity.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_GB2215207A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>GB2215207A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_GB2215207A3</originalsourceid><addsrcrecordid>eNrjZNANDg0OcfT0c3VRCHL1cXUMdlUI8HAM8nV0dg0N8XR29FFw8Q92dHdVCPXzDAnmYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXx7k5GRoamRgbmjsaEVQAAOKYkoA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUSTAINED RELEASE PHARMACEUTICAL DOSAGE UNITS</title><source>esp@cenet</source><creator>MICHAEL GORDON BROOK</creator><creatorcontrib>MICHAEL GORDON BROOK</creatorcontrib><description>A sustained release pharmaceutical formulation is disclosed having the capability of a linear rate of drug release over a significant period (e.g. at least 20 hours). The formulation essentially comprises a shaped, solid formulation containing a drug and a non-cross-linked hydrophilic polymer which constitutes the binder for the formulation, said polymer having a swell factor between about 50 and 250 % such that when the formulation is contacted with body fluid it swells and becomes soft and rubbery but retains its integrity.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>1989</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19890920&amp;DB=EPODOC&amp;CC=GB&amp;NR=2215207A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19890920&amp;DB=EPODOC&amp;CC=GB&amp;NR=2215207A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MICHAEL GORDON BROOK</creatorcontrib><title>SUSTAINED RELEASE PHARMACEUTICAL DOSAGE UNITS</title><description>A sustained release pharmaceutical formulation is disclosed having the capability of a linear rate of drug release over a significant period (e.g. at least 20 hours). The formulation essentially comprises a shaped, solid formulation containing a drug and a non-cross-linked hydrophilic polymer which constitutes the binder for the formulation, said polymer having a swell factor between about 50 and 250 % such that when the formulation is contacted with body fluid it swells and becomes soft and rubbery but retains its integrity.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1989</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNANDg0OcfT0c3VRCHL1cXUMdlUI8HAM8nV0dg0N8XR29FFw8Q92dHdVCPXzDAnmYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXx7k5GRoamRgbmjsaEVQAAOKYkoA</recordid><startdate>19890920</startdate><enddate>19890920</enddate><creator>MICHAEL GORDON BROOK</creator><scope>EVB</scope></search><sort><creationdate>19890920</creationdate><title>SUSTAINED RELEASE PHARMACEUTICAL DOSAGE UNITS</title><author>MICHAEL GORDON BROOK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_GB2215207A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1989</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>MICHAEL GORDON BROOK</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MICHAEL GORDON BROOK</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUSTAINED RELEASE PHARMACEUTICAL DOSAGE UNITS</title><date>1989-09-20</date><risdate>1989</risdate><abstract>A sustained release pharmaceutical formulation is disclosed having the capability of a linear rate of drug release over a significant period (e.g. at least 20 hours). The formulation essentially comprises a shaped, solid formulation containing a drug and a non-cross-linked hydrophilic polymer which constitutes the binder for the formulation, said polymer having a swell factor between about 50 and 250 % such that when the formulation is contacted with body fluid it swells and becomes soft and rubbery but retains its integrity.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_GB2215207A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title SUSTAINED RELEASE PHARMACEUTICAL DOSAGE UNITS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T22%3A15%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MICHAEL%20GORDON%20BROOK&rft.date=1989-09-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EGB2215207A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true